The rate of bone loss slows after 1–2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (<scp>START</scp>) bone mineral density substudyAndrew Carr, Birgit Grund, AV Schwartz et al.|HIV Medicine|2019Cited by 19
A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV LipoatrophyJanet Raboud, Sharon Walmsley, Steven Grinspoon et al.|HIV Clinical Trials|2010Cited by 5